Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 25 Apr 2024  |  Global

    Frost Radar : Healthcare Enterprise Managed Cloud Services, 2024

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    In the cloud industry and most other technology-related industries, 2024 will be all about artificial intelligence (AI). Businesses are grappling with how they can leverage AI (particularly generative AI) to meet their goals. Public cloud providers are at the forefront of efforts to accelerate customers AI adoption by developing foundational model...

    $4,950.00
  2. 24 Apr 2024  |  Global

    Global Patient Engagement Platforms and Solutions, Forecast to 2028

    Competitive Strategies to Seize Growth Opportunities

    The global patient engagement industry is undergoing substantial expansion. The increasing emphasis on patient-centric healthcare, widespread adoption of digital health solutions, and higher demand for enhanced healthcare outcomes are fueling this industry s growth. This comprehensive Frost & Sullivan analysis provides an in-depth look at this d...

    $4,950.00
  3. 18 Jan 2024  |  Global

    Top 5 Growth Opportunities in Digital Health, 2024

    How Disruptive Technologies are Changing Business Models

    The healthcare landscape is experiencing a profound shift as it shifts away from traditional fee-for-service models toward value-based care. This transition emphasizes collaboration among healthcare stakeholders, fostering a patient-centric approach. The focus is not merely on the quantity of services delivered but also on the quality of care, enco...

    $2,450.00
  4. 28 Nov 2023  |  Global

    Growth Opportunities in Obesity Drugs and Delivery Platforms

    GLP-1-based Drugs, Along With Injector and Nanomaterial Delivery Platforms, Drive Transformational Industry Growth

    The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

    $4,950.00
  5. 10 May 2023  |  Global

    Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

    Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

    This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

    $4,950.00
  6. 03 Apr 2023  |  Global

    Global Next generation Diagnostics, Outlook 2023

    Automation and Digitization Drive the Next Growth Phase Post-COVID-19

    As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...

    $4,950.00

    Special Price $4,455.00 save 10 %

  7. 27 Mar 2023  |  Global

    Global Pharmaceutical Industry Outlook, 2023

    Transformative Megatrends are Expanding the Vendor Ecosystem

    This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

    $4,950.00

    Special Price $4,455.00 save 10 %

  8. 13 Jan 2023  |  Global

    Global Life Science Instrumentation and Research Tool Growth Opportunities

    Automation and Robotization to Ensure Industrywide Streamlining and Increase Future Growth Potential

    New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...

    $4,950.00

    Special Price $4,455.00 save 10 %

  9. 30 Dec 2022  |  Global

    Growth Opportunities in Global Pharmaceutical Logistics

    Cold chain Investments and Hybrid Clinical Trials to Ensure Transformational Growth of Pharmaceutical Logistics

    Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure ...

    $2,450.00

    Special Price $2,205.00 save 10 %

  10. 21 Dec 2022  |  Global

    Antibody-drug Conjugates: Technology Growth Opportunities

    Disruptive Technologies and a Conducive Funding Environment are Fostering Growth

    Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

    $4,950.00

    Special Price $4,455.00 save 10 %